Smith & Nephew Plc

$42
SNN - NYSE
Dividend yield
Dividend has grown by 7.07% in last three years.
2.20 %
$0.75 anually
P/E ratio
-
Payout ratio
Proportion of net income paid out as dividends to shareholders
-
Yearly
Company profitability (EPS)
-
past 12 months
CASH payout ratio
Smith & Nephew Plc last quarter cash income being paid in the form of dividends.
Last quarter
Become our supporter to unlock all data!
Stock volatility (Beta)
See how volatile SNN stock is compared to other dividend stocks and to its sector
past 12 months
Become our supporter to unlock all data!
Company debt level
How much debt Smith & Nephew Plc have in comparison to other dividend stocks
Become our supporter to unlock all data!
Smith & Nephew Plc description

Smith & Nephew Plc engages in the development, manufacture, marketing, and sale of medical devices. It offers the following products and services: sports medicine joint repair; arthroscopic enabling technologies; trauma and extremities; other surgical businesses; knee and hip implants, and advanced wound care, wound bioactives, and wound devices. It operates through the United Kingdom, United States of America, and Other geographical segments.

The company was founded by Thomas James Smith in 1856 and is headquartered in London, the United Kingdom.

Company profile
Market cap
Large (18.34B)
Company CEO
Roland D. Diggelmann
Price history Smith & Nephew Plc
Loading price stock history...
SNN dividends payouts
Similar stocks as Smith & Nephew Plc